(Q58434824)
Statements
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab (English)
E Botti
M Teoli
G Spallone
M Bavetta
1 August 2013